PDS Biotechnology Statistics
Share Statistics
PDS Biotechnology has 45.71M
shares outstanding. The number of shares has increased by 21.57%
in one year.
| Shares Outstanding | 45.71M |
| Shares Change (YoY) | 21.57% |
| Shares Change (QoQ) | 19.19% |
| Owned by Institutions (%) | 11.52% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 16,593 |
| FTD / Avg. Volume | 2.85% |
Short Selling Information
The latest short interest is 2.88M, so 6.29% of the outstanding
shares have been sold short.
| Short Interest | 2.88M |
| Short % of Shares Out | 6.29% |
| Short % of Float | 6.49% |
| Short Ratio (days to cover) | 12.88 |
Valuation Ratios
The PE ratio is -1.58 and the forward
PE ratio is -1.66.
PDS Biotechnology's PEG ratio is
0.
| PE Ratio | -1.58 |
| Forward PE | -1.66 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 3.13 |
| P/FCF Ratio | -1.69 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for PDS Biotechnology.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.64,
with a Debt / Equity ratio of 1.15.
| Current Ratio | 2.64 |
| Quick Ratio | 2.64 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | -0.65 |
| Debt / FCF | -0.62 |
| Interest Coverage | -7.77 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,567,083.33 |
| Employee Count | 24 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -869K |
| Effective Tax Rate | 2.26% |
Stock Price Statistics
The stock price has increased by -47.93% in the
last 52 weeks. The beta is 1.24, so PDS Biotechnology's
price volatility has been higher than the market average.
| Beta | 1.24 |
| 52-Week Price Change | -47.93% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 59.96 |
| Average Volume (20 Days) | 581,676 |
Income Statement
| Revenue | n/a |
| Gross Profit | -59.79K |
| Operating Income | -36.32M |
| Net Income | -37.61M |
| EBITDA | -33.75M |
| EBIT | -33.81M |
| Earnings Per Share (EPS) | -1079.45 |
Full Income StatementBalance Sheet
The company has 41.69M in cash and 21.83M in
debt, giving a net cash position of 19.86M.
| Cash & Cash Equivalents | 41.69M |
| Total Debt | 21.83M |
| Net Cash | 19.86M |
| Retained Earnings | -182.11M |
| Total Assets | 47.03M |
| Working Capital | 24.2M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -35.03M
and capital expenditures -29K, giving a free cash flow of -35.06M.
| Operating Cash Flow | -35.03M |
| Capital Expenditures | -29K |
| Free Cash Flow | -35.06M |
| FCF Per Share | -0.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
